Company KYORIN Pharmaceutical Co., Ltd.

4569

JP3247090008

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Ratings for KYORIN Pharmaceutical Co., Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-02 am EDT			5-day change	1st Jan Change
1,839 ^JPY	+0.05%		+0.60%	+3.31%

2023	ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan	MT
2021	KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500	CI

Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.

Number of employees: 2,138

JPY in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	105,534	100.0 %	113,270	100.0 %	+7.33%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 100.0 %	105,534	100.0 %	113,270	100.0 %	+7.33%

Managers	Title	Age	Since
Minoru Hogawa CHM	Chairman	70	05-12-31
Yutaka Ogihara PSD	President	56	11-05-31
Yasuyuki Shimokawa CTO	Chief Tech/Sci/R&D Officer	-	-
Michiro Onota BRD	Director/Board Member	63	19-05-31
Yasushi Kurose PRN	Corporate Officer/Principal	-	-
Kenji Akutsu AUD	Comptroller/Controller/Auditor	68	15-03-31
Yoshinobu Hashimoto PRN	Corporate Officer/Principal	-	-
Tomiharu Matsumoto AUD	Comptroller/Controller/Auditor	70	06-02-28

Members of the board	Title	Age	Since
Ken Shigematsu BRD	Director/Board Member	75	17-05-31
Yutaka Ogihara PSD	President	56	11-05-31
Tomiharu Matsumoto AUD	Comptroller/Controller/Auditor	70	06-02-28
Minoru Hogawa CHM	Chairman	70	05-12-31
Noriyuki Shikanai BRD	Director/Board Member	75	13-05-31
Kenji Akutsu AUD	Comptroller/Controller/Auditor	68	15-03-31
Michiro Onota BRD	Director/Board Member	63	19-05-31
Hiromi Watanabe BRD	Director/Board Member	76	19-05-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	64,607,936	36,933,379 ( 57.17 %)	7,159,124 ( 11.08 %)	57.17 %

Name	Equities	%	Valuation
Ogihara Family 18.05 %	11,660,984	18.05 %	140 M ¥
KYORIN PHARMACEUTICAL CO., LTD. 10.00 %	6,461,800	10.00 %	77 M ¥
Kopernik Global Investors LLC 6.232 %	4,026,400	6.232 %	48 M ¥
Kyorin Group Employee Ownership Plan 3.435 %	2,219,000	3.435 %	27 M ¥
Mariko Ogihara 2.724 %	1,760,000	2.724 %	21 M ¥
KAKEN PHARMACEUTICAL CO., LTD. 2.480 %	1,602,000	2.480 %	19 M ¥
Akira Ogihara 2.467 %	1,594,000	2.467 %	19 M ¥
ONO PHARMACEUTICAL CO., LTD. 1.494 %	965,000	1.494 %	12 M ¥
NISSHIN SEIFUN GROUP INC. 1.167 %	754,000	1.167 %	9 M ¥
KISSEI PHARMACEUTICAL CO., LTD. 1.068 %	690,000	1.068 %	8 M ¥

Name	Equities	%	Valuation
KYORIN PHARMACEUTICAL CO., LTD. 10.00%	6,461,800	10.00%	77,364,870 $
ONO PHARMACEUTICAL CO., LTD. 0.36%	1,812,000	0.36%	29,386,853 $
KAKEN PHARMACEUTICAL CO., LTD. 1.85%	852,000	1.85%	19,472,520 $
NISSHIN SEIFUN GROUP INC. 0.36%	1,098,075	0.36%	15,232,804 $
AIN HOLDINGS INC. 1.13%	400,000	1.13%	14,605,040 $
KISSEI PHARMACEUTICAL CO., LTD. 0.92%	454,000	0.92%	10,604,182 $
TOHO HOLDINGS CO., LTD. 0.49%	374,980	0.49%	9,048,380 $
MEDIPAL HOLDINGS CORPORATION 0.19%	431,280	0.19%	6,611,182 $
VITAL KSK HOLDINGS, INC. 1.16%	603,200	1.16%	5,005,909 $
ALFRESA HOLDINGS CORPORATION 0.16%	319,272	0.16%	4,688,506 $

KYORIN Pharmaceutical Co., Ltd.

4-6 Kanda Surugadai Chiyoda-ku

101-8311, Tokyo

http://www.kyorin-gr.co.jp

address KYORIN Pharmaceutical Co., Ltd.(4569)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

1,839 JPY

Average target price

1,500 JPY

Spread / Average Target

-18.43%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
KYORIN PHARMACEUTICAL CO., LTD.	+3.31%	691M
ELI LILLY AND COMPANY	+26.08%	662B
NOVO NORDISK A/S	+22.62%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	289B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+4.23%	198B
ROCHE HOLDING AG	-10.88%	194B
AMGEN INC.	+8.08%	167B

Other Pharmaceuticals